Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-5172A in treatment-naïve chronic HCV genotype 1/4/6 infection
CTR20160033Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of grazoprevir in hepatitis C virus infection, chronic hepatitis C (CHC), sponsored by Merck & Co.. Started Mar 2016; status: completed.
02
Drugs
grazoprevir
03
Conditions
hepatitis C virus infectionchronic hepatitis C (CHC)
Beyond the preview
Go deeper on CTR20160033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160033.